{"title":"奥氮平治疗精神分裂症阳性和阴性症状的疗效观察。","authors":"R Gray","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In the second of this series of updates on recent advances in medication, RICHARD GRAY summarises trials into the novel antipsychotic olanzapine, which has been shown to compare well to haloperidol, and is now widely used for treating schizophrenia and related psychoses.</p>","PeriodicalId":79511,"journal":{"name":"Mental health care","volume":"1 6","pages":"193-4"},"PeriodicalIF":0.0000,"publicationDate":"1998-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Olanzapine: efficacy in treating the positive and negative symptoms of schizophrenia.\",\"authors\":\"R Gray\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In the second of this series of updates on recent advances in medication, RICHARD GRAY summarises trials into the novel antipsychotic olanzapine, which has been shown to compare well to haloperidol, and is now widely used for treating schizophrenia and related psychoses.</p>\",\"PeriodicalId\":79511,\"journal\":{\"name\":\"Mental health care\",\"volume\":\"1 6\",\"pages\":\"193-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mental health care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mental health care","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Olanzapine: efficacy in treating the positive and negative symptoms of schizophrenia.
In the second of this series of updates on recent advances in medication, RICHARD GRAY summarises trials into the novel antipsychotic olanzapine, which has been shown to compare well to haloperidol, and is now widely used for treating schizophrenia and related psychoses.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
